CN105535390A - 一种治疗冠心病的中药汤剂及其制备方法 - Google Patents
一种治疗冠心病的中药汤剂及其制备方法 Download PDFInfo
- Publication number
- CN105535390A CN105535390A CN201610033351.1A CN201610033351A CN105535390A CN 105535390 A CN105535390 A CN 105535390A CN 201610033351 A CN201610033351 A CN 201610033351A CN 105535390 A CN105535390 A CN 105535390A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine decoction
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 38
- 229940079593 drug Drugs 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 27
- 239000009636 Huang Qi Substances 0.000 claims description 26
- 210000000582 semen Anatomy 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229910052956 cinnabar Inorganic materials 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 206010015037 epilepsy Diseases 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗冠心病的中药汤剂及其制备方法,该中药汤剂由以下重量份的原料药制备而成:生山楂20~35份、黄芪15~25份、西洋参8~12份、丹参18~25份、全瓜蒌18~25份、薤白6~15份、当归6~15份、五味子6~15份、枣仁15~25份、石菖蒲8~12份、茯苓8~15份、莲子心8~15份、炙甘草6~15份、朱砂1~3份和琥珀5~10份。使用本发明制备的药物中药汤剂可标本兼治,治愈后不反弹,副作用小,经济实惠,疗效显著,可自行操作,方法简单。
Description
技术领域
本发明属于中药制剂技术领域,具体涉及一种治疗冠心病的中药汤剂及其制备方法。
背景技术
中医药是中华民族的宝贵财富,为中华民族的繁衍昌盛做出了巨大贡献。传统医学的治疗理念正逐渐为世界所接受,传统医药受到国际社会越来越多的关注,世界范围内对中医药的需求日益增长,这为中医药的发展提供了广阔的空间。中国民间用中医药偏方、奇方成功治愈疑难杂症的例子不胜枚举。冠心病是一种最常见的心脏病,是指因冠状动脉狭窄、供血不足而引起的心肌机能障碍和(或)器质性病变,故又称缺血性心脏病(IHD)。症状表现胸腔中央发生一种压榨性的疼痛,并可迁延至颈、颔、手臂、后背及胃部。发作的其他可能症状有眩晕、气促、出汗、寒颤、恶心及昏厥。严重患者可能因为心力衰竭而死亡。西医治疗冠心病会用许多种西药,众所周知西药有一定副作用多少会影响患者身体健康,该中药汤剂及制成的中成药能够有效治疗冠心病而且没有副作用,这说明中医药在某些疾病治疗中不可缺少的重要地位。
发明内容
本发明的目的是提供一种治疗冠心病的中药汤剂及其制备方法,用该方法制备的中药汤剂可标本兼治,治愈后不反弹,副作用小,经济实惠,疗效显著,可自行操作,方法简单。
为了达到上述目的,本发明采用如下技术方案:
本发明提供了一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20~35份、黄芪15~25份、西洋参8~12份、丹参18~25份、全瓜蒌18~25份、薤白6~15份、当归6~15份、五味子6~15份、枣仁15~25份、石菖蒲8~12份、茯苓8~15份、莲子心8~15份、炙甘草6~15份、朱砂1~3份和琥珀5~10份。
根据上述治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20~30份、黄芪20~25份、西洋参8~10份、丹参18~20份、全瓜蒌18~22份、薤白10~15份、当归6~8份、五味子6~10份、枣仁20~25份、石菖蒲8~10份、茯苓8~12份、莲子心8~13份、炙甘草6~10份、朱砂1~2份和琥珀7~10份。
根据上述治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30~35份、黄芪15~20份、西洋参10~12份、丹参20~25份、全瓜蒌22~25份、薤白6~10份、当归8~15份、五味子10~15份、枣仁15~20份、石菖蒲10~12份、茯苓12~15份、莲子心13~15份、炙甘草10~15份、朱砂2~3份和琥珀5~7份。
根据上述治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪20份、西洋参10份、丹参20份、全瓜蒌20份、薤白10份、当归10份、五味子10份、枣仁20份、石菖蒲10份、茯苓10份、莲子心10份、炙甘草10份、朱砂2份和琥珀6份。
所述治疗冠心病的中药汤剂的制备方法,按上述配方称取各组分原料,加入各组分原料总质量3~5倍量的水煎煮25~30分钟,即可服用,日服1剂,煎水分2次服完。
本发明中药膏剂中各味原料药的药理:
生山楂:味酸甘,性微温;归脾胃肝经。具有消食化积、活血散瘀之功效。常用于治疗食滞不化,肉积不消,脘腹胀满,腹痛泄泻及产后瘀阻腹痛,恶露不尽,还可用于疝气偏坠胀痛,生山楂偏重消肉积,降血压和降血脂。
黄芪:味甘,微温;具有补气固表,利尿托毒,排脓,敛疮生肌功效,用于气虚乏力,食少便溏,中气下陷,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴,慢性肾炎蛋白尿,糖尿病等症。
西洋参:抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,冠心病患者症状表现为气阴两虚、心慌气短可长期服用西洋参,疗效显著。西洋参的功效还在于可以调节血压,可有效降低暂时性和持久性血压,有助于高血压、心律失常、冠心病、急性心肌梗塞、脑血栓等疾病的恢复。
丹参:味苦,平,微温。入心、肝经。具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
全瓜蒌:味微酸、甜。清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,肺痈,肠痈肿痛,大便秘结。
薤白:味辛;苦;性温。主治通阳散结,行气导滞。胸痹心痛彻背;胸脘痞闷;咳喘痰多;脘腹疼痛;泄痢后重;白带;疮疖痈肿。
当归:味甘、辛、苦,性温;归肝、心、脾经。功能主治:补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
五味子:味酸、甘,性温。归肺、心、肾经。功效敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。
枣仁:味甘,性平。归经:心经;脾经;肝经;胆经。功能:宁心安神;养肝;敛汗。主治:虚烦不眠;惊悸怔忡;体虚自汗、盗汗。
石菖蒲:辛、苦,温。归心、胃经。功能化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。
茯苓:味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。
莲子心:性味苦,寒。清心,去热,止血,涩精。治心烦,口渴,吐血,遗精,平和五脏之气。
炙甘草:炙甘草含有甘草甜素、甘草次酸、甘草多糖等多种化甘草学成分,具有抗炎及抗变态反应作用,可调节机体免疫功能,抗肿瘤和止痛作用。因此炙甘草的主要功效是和中缓急,润肺,解毒,调和诸药。常用于脾胃虚弱,倦怠乏力,心动悸,脉结代,可解附子毒。
朱砂:甘,微寒,有小毒。归心经。功效清心镇惊,安神解毒,用于心悸易惊,失眠多梦,癫痫发狂,小儿惊风,视物昏花,口疮,喉痹,疮疡肿毒,心神不宁,心悸失眠,惊风,癫痫,疮疡肿痛,咽喉肿痛,口舌生疮。[
琥珀:甘,平。功能镇静,利尿,活血。用于惊风,癫痫,心悸,失眠,小便不利,尿痛,尿血,闭经。
本发明的积极有益效果:
(1)本发明根据中医传统理论,在组传秘方的基础上结合发明人的长期临床实践,该原料药生山楂、黄芪、西洋参、丹参、全瓜蒌、薤白、当归、五味子、枣仁、石菖蒲、茯苓、莲子心、炙甘草、朱砂和琥珀为精选原料,各味药物之间配伍合理,功效互补,能产生较好的协同作用。临床应用表明,该药具有活血通径,润肠通便,凉血散瘀,祛瘀消肿,补气固表,利尿托毒,排脓,敛疮生肌,调节免疫,抑菌,抗癌,降血压,调节血脂的功效,从而有效的修复细胞,清除血液里的垃圾,逐渐将血管壁上的胆固醇血脂溶解,消除血管壁的粥样血脂沉淀,改善血管弹性,预防血管粥样硬化,起到了显效的作用。
(2)本发明为纯中药产品,安全,治疗费用低,见效快,一般1~2个疗程见效,4~6个疗程治愈,患者痛苦小、不抗药,毒副作用小,易被患者接受。
病例统计:
发明人从2009~2014年共收治有记载的冠心病的患者778例,共治愈693例,占89.1%;有效56例,占7.2%;治愈率为96.3%。
典型病例:
病例1张女士59,6年来患有高血压,常有心前区及左胸痛,经治疗高血压不稳定,自觉左胸痛、头闷、走路不稳、神疲中医辨证为气阴两虚,服用本发明的中药汤剂,日服1剂,煎水分2次服完,服用1个疗程后,自觉体力精神变佳,复查心电图有所好转,后继续服用3个疗程,身体一切恢复正常。
病例2戴女士64岁,治疗诊断及性冠脉综合征,服用本发明的中药汤剂,日服1剂,煎水分2次服完,服用一个疗程后,自觉体力精神变佳,复查心电图有所好转,后继续服用3个疗程,身体一切恢复正常,半年未复发。
病例3王女士48岁心绞痛反复发作,服用本发明的中药汤剂,日服1剂,煎水分2次服完,服用2个疗程,自觉体力精神变佳,复查心电图有所好转,后继续服用4个疗程,身体一切恢复正常,半年未复发。
具体实施方式:
以下结合实施例对本发明进一步的描述,但并不限制本发明的内容。
实施例1:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20~35份、黄芪15~25份、西洋参8~12份、丹参18~25份、全瓜蒌18~25份、薤白6~15份、当归6~15份、五味子6~15份、枣仁15~25份、石菖蒲8~12份、茯苓8~15份、莲子心8~15份、炙甘草6~15份、朱砂1~3份和琥珀5~10份。
上述治疗冠心病的中药汤剂的制备方法,按上述配方称取各组分原料,加入各组分原料总质量3~5倍量的水煎煮25~30分钟,即可服用,日服1剂,煎水分2次服完。
实施例2:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪20份、西洋参10份、丹参20份、全瓜蒌20份、薤白10份、当归10份、五味子10份、枣仁20份、石菖蒲10份、茯苓10份、莲子心10份、炙甘草10份、朱砂2份和琥珀6份。
本实施例的制备方法与实施例1的制备方法相同。
实施例3:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20份、黄芪16份、西洋参10份、丹参20份、全瓜蒌25份、薤白13份、当归8份、五味子8份、枣仁16份、石菖蒲9份、茯苓10份、莲子心10份、炙甘草12份、朱砂1份和琥珀6份。
本实施例的制备方法与实施例1的制备方法相同。
实施例4:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂26份、黄芪18份、西洋参11份、丹参22份、全瓜蒌20份、薤白14份、当归6份、五味子13份、枣仁17份、石菖蒲9份、茯苓8份、莲子心12份、炙甘草7份、朱砂2份和琥珀8份。
本实施例的制备方法与实施例1的制备方法相同。
实施例5:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂33份、黄芪16份、西洋参11份、丹参24份、全瓜蒌19份、薤白12份、当归7份、五味子8份、枣仁24份、石菖蒲10份、茯苓13份、莲子心11份、炙甘草12份、朱砂3份和琥珀8份。
本实施例的制备方法与实施例1的制备方法相同。
实施例6:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂21份、黄芪16份、西洋参10份、丹参21份、全瓜蒌23份、薤白14份、当归8份、五味子11份、枣仁16份、石菖蒲8份、茯苓10份、莲子心11份、炙甘草13份、朱砂3份和琥珀10份。
本实施例的制备方法与实施例1的制备方法相同。
实施例7:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂28份、黄芪18份、西洋参10份、丹参19份、全瓜蒌23份、薤白9份、当归7份、五味子8份、枣仁19份、石菖蒲10份、茯苓14份、莲子心13份、炙甘草11份、朱砂1份和琥珀8份。
本实施例的制备方法与实施例1的制备方法相同。
实施例8:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂35份、黄芪20份、西洋参11份、丹参19份、全瓜蒌22份、薤白12份、当归13份、五味子6份、枣仁17份、石菖蒲9份、茯苓11份、莲子心14份、炙甘草15份、朱砂2份和琥珀8份。
本实施例的制备方法与实施例1的制备方法相同。
实施例9:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20份、黄芪18份、西洋参10份、丹参20份、全瓜蒌23份、薤白9份、当归7份、五味子12份、枣仁23份、石菖蒲10份、茯苓9份、莲子心13份、炙甘草12份、朱砂2.5份和琥珀7份。
本实施例的制备方法与实施例1的制备方法相同。
实施例10:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪17份、西洋参8份、丹参24份、全瓜蒌19份、薤白11份、当归9份、五味子7份、枣仁20份、石菖蒲10份、茯苓15份、莲子心8份、炙甘草7份、朱砂1.5份和琥珀6份。
本实施例的制备方法与实施例1的制备方法相同。
实施例11:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂22份、黄芪23份、西洋参11份、丹参22份、全瓜蒌19份、薤白7份、当归6份、五味子11份、枣仁16份、石菖蒲9份、茯苓9份、莲子心10份、炙甘草7份、朱砂1份和琥珀8份。
本实施例的制备方法与实施例1的制备方法相同。
实施例12:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪15份、西洋参11份、丹参19份、全瓜蒌23份、薤白12份、当归9份、五味子8份、枣仁21份、石菖蒲10份、茯苓14份、莲子心11份、炙甘草9份、朱砂3份和琥珀9份。
本实施例的制备方法与实施例1的制备方法相同。
实施例13:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪16份、西洋参11份、丹参19份、全瓜蒌23份、薤白7份、当归14份、五味子8份、枣仁19份、石菖蒲11份、茯苓12份、莲子心15份、炙甘草6份、朱砂1份和琥珀6份。
本实施例的制备方法与实施例1的制备方法相同。
实施例14:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂35份、黄芪15份、西洋参12份、丹参19份、全瓜蒌20份、薤白8份、当归7份、五味子13份、枣仁16份、石菖蒲11份、茯苓15份、莲子心12份、炙甘草7份、朱砂1份和琥珀10份。
本实施例的制备方法与实施例1的制备方法相同。
实施例15:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂30份、黄芪23份、西洋参11份、丹参23份、全瓜蒌20份、薤白14份、当归7份、五味子14份、枣仁23份、石菖蒲11份、茯苓13份、莲子心10份、炙甘草13份、朱砂3份和琥珀7份。
本实施例的制备方法与实施例1的制备方法相同。
实施例16:
一种治疗冠心病的中药汤剂,由以下重量份的原料药制备而成:生山楂20份、黄芪23份、西洋参10份、丹参23份、全瓜蒌20份、薤白11份、当归6~15份、五味子10份、枣仁22份、石菖蒲12份、茯苓8份、莲子心13份、炙甘草12份、朱砂3份和琥珀10份。
本实施例的制备方法与实施例1的制备方法相同。
Claims (5)
1.一种治疗冠心病的中药汤剂,其特征在于:由以下重量份的原料药制备而成:生山楂20~35份、黄芪15~25份、西洋参8~12份、丹参18~25份、全瓜蒌18~25份、薤白6~15份、当归6~15份、五味子6~15份、枣仁15~25份、石菖蒲8~12份、茯苓8~15份、莲子心8~15份、炙甘草6~15份、朱砂1~3份和琥珀5~10份。
2.根据权利要求1所述治疗冠心病的中药汤剂,其特征在于:由以下重量份的原料药制备而成:生山楂20~30份、黄芪20~25份、西洋参8~10份、丹参18~20份、全瓜蒌18~22份、薤白10~15份、当归6~8份、五味子6~10份、枣仁20~25份、石菖蒲8~10份、茯苓8~12份、莲子心8~13份、炙甘草6~10份、朱砂1~2份和琥珀7~10份。
3.根据权利要求1所述治疗冠心病的中药汤剂,其特征在于:由以下重量份的原料药制备而成:生山楂30~35份、黄芪15~20份、西洋参10~12份、丹参20~25份、全瓜蒌22~25份、薤白6~10份、当归8~15份、五味子10~15份、枣仁15~20份、石菖蒲10~12份、茯苓12~15份、莲子心13~15份、炙甘草10~15份、朱砂2~3份和琥珀5~7份。
4.根据权利要求1所述治疗冠心病的中药汤剂,其特征在于:由以下重量份的原料药制备而成:生山楂30份、黄芪20份、西洋参10份、丹参20份、全瓜蒌20份、薤白10份、当归10份、五味子10份、枣仁20份、石菖蒲10份、茯苓10份、莲子心10份、炙甘草10份、朱砂2份和琥珀6份。
5.根据权利要求1~4任一项所述治疗冠心病的中药汤剂的制备方法,其特征在于:按上述配方称取各组分原料,加入各组分原料总质量3~5倍量的水煎煮25~30分钟,即可服用,日服1剂,煎水分2次服完。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610033351.1A CN105535390A (zh) | 2016-01-19 | 2016-01-19 | 一种治疗冠心病的中药汤剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610033351.1A CN105535390A (zh) | 2016-01-19 | 2016-01-19 | 一种治疗冠心病的中药汤剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105535390A true CN105535390A (zh) | 2016-05-04 |
Family
ID=55815300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610033351.1A Pending CN105535390A (zh) | 2016-01-19 | 2016-01-19 | 一种治疗冠心病的中药汤剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535390A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110051763A (zh) * | 2019-05-24 | 2019-07-26 | 朱玉水 | 一种治疗心血管疾病的配方 |
CN112755150A (zh) * | 2021-01-25 | 2021-05-07 | 王萍 | 一种治疗心脏病的中药组合物 |
CN112972554A (zh) * | 2021-03-11 | 2021-06-18 | 青海雪峰牦牛乳业有限责任公司 | 治疗冠心病或冠状动脉粥样硬化疾病的中药组合物及其制备方法 |
CN112972567A (zh) * | 2019-12-16 | 2021-06-18 | 孙立文 | 一种辅助针灸拔罐治疗心脏病的中药及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102114085A (zh) * | 2010-06-11 | 2011-07-06 | 李银春 | 一种治疗冠心病的中药口服汤剂 |
CN102908544A (zh) * | 2012-09-29 | 2013-02-06 | 花砚 | 一种治疗冠心病的中药汤剂及其制备方法 |
CN103446260A (zh) * | 2012-05-30 | 2013-12-18 | 吕奎荣 | 一种治疗冠心病的中药组合物 |
CN104740289A (zh) * | 2013-12-26 | 2015-07-01 | 曹红云 | 一种治疗冠心病的中药 |
-
2016
- 2016-01-19 CN CN201610033351.1A patent/CN105535390A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102114085A (zh) * | 2010-06-11 | 2011-07-06 | 李银春 | 一种治疗冠心病的中药口服汤剂 |
CN103446260A (zh) * | 2012-05-30 | 2013-12-18 | 吕奎荣 | 一种治疗冠心病的中药组合物 |
CN102908544A (zh) * | 2012-09-29 | 2013-02-06 | 花砚 | 一种治疗冠心病的中药汤剂及其制备方法 |
CN104740289A (zh) * | 2013-12-26 | 2015-07-01 | 曹红云 | 一种治疗冠心病的中药 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110051763A (zh) * | 2019-05-24 | 2019-07-26 | 朱玉水 | 一种治疗心血管疾病的配方 |
CN112972567A (zh) * | 2019-12-16 | 2021-06-18 | 孙立文 | 一种辅助针灸拔罐治疗心脏病的中药及其制备方法 |
CN112755150A (zh) * | 2021-01-25 | 2021-05-07 | 王萍 | 一种治疗心脏病的中药组合物 |
CN112972554A (zh) * | 2021-03-11 | 2021-06-18 | 青海雪峰牦牛乳业有限责任公司 | 治疗冠心病或冠状动脉粥样硬化疾病的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101912468A (zh) | 治疗乳腺炎的中草药 | |
CN101502588B (zh) | 一种美容祛痘组合物及其制备方法 | |
CN103550696B (zh) | 一种治疗肺癌的药物 | |
CN101199738B (zh) | 治疗咳喘病的药物 | |
CN105535390A (zh) | 一种治疗冠心病的中药汤剂及其制备方法 | |
CN103110762A (zh) | 一种治疗骨折久不愈合的中药组合物 | |
CN104042891A (zh) | 缓解产妇大便秘结的中药组合物及其制备方法 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN103893670B (zh) | 一种治疗心脑血管病的中药药丸 | |
CN101095828A (zh) | 一种治疗糖尿病性便秘的中药组合 | |
CN103127366B (zh) | 一种治疗糖尿病性心脏病的中药制剂 | |
CN102319352A (zh) | 一种治疗心脏病的中药配方 | |
CN102293964B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN102058843A (zh) | 一种治疗脂肪肝的中药组合物 | |
CN101313994A (zh) | 用于治疗心房颤动中药胶囊 | |
CN101129841A (zh) | 一种治疗乳汁自出的中药组合物 | |
CN103520697A (zh) | 治疗气阴不足证型胸痹心痛的中药 | |
CN102293941B (zh) | 一种治疗糖尿病的中药组合物 | |
CN101085313A (zh) | 一种治疗倒经的中药制剂 | |
CN103432544B (zh) | 用于治疗上消化道出血的汤剂 | |
CN104825795A (zh) | 治疗心律不齐的中药胶囊 | |
CN103432422B (zh) | 一种治疗慢性胃炎的中药 | |
CN105456499A (zh) | 一种用于治疗便秘的中药制剂及制备方法 | |
CN105709005A (zh) | 一种乳康丸 | |
CN103656199A (zh) | 一种治疗肾阴不足证型咳嗽的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160504 |